Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

6.9%

2 terminated/withdrawn out of 29 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

34%

10 trials in Phase 3/4

Results Transparency

63%

10 of 16 completed trials have results

Key Signals

6 recruiting10 with results

Enrollment Performance

Analytics

Phase 3

7(30.4%)

Phase 2

5(21.7%)

N/A

4(17.4%)

Phase 1

4(17.4%)

Phase 4

3(13.0%)

23Total

Phase 3(7)

Phase 2(5)

N/A(4)

Phase 1(4)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (29)

Showing 20 of 29 trials

NCT06216132Phase 1Completed

Study of the BIOPIN 6 Naltrexone Implant in Healthy Adults

Role: collaborator

NCT05267613Phase 3Active Not Recruiting

Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.

Role: collaborator

NCT04998812Phase 4Completed

A Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During Pregnancy

Role: collaborator

NCT04093388Not ApplicableRecruiting

Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama

Role: collaborator

NCT06639282Phase 2Recruiting

Repurposing Siponimod for Alzheimer's Disease

Role: collaborator

NCT07333482Not ApplicableRecruiting

Flourish: Exploring the Early Infant Gut Microbiome

Role: collaborator

NCT05294991Not ApplicableRecruiting

Wellness App for Sleep Disturbance in Hematological Cancer Patients

Role: collaborator

NCT06643741Recruiting

Non-Invasive Preeclampsia Screening and Biobank

Role: collaborator

NCT04998851Phase 4Completed

A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab

Role: collaborator

NCT04250922Phase 2Active Not Recruiting

LAM561 With RT and TMZ for Adults With Glioblastoma

Role: collaborator

NCT03631225Active Not Recruiting

The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis

Role: collaborator

NCT05634954Phase 1Withdrawn

Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer

Role: collaborator

NCT04536298Phase 3Completed

Vitamin D for COVID-19 Trial

Role: collaborator

NCT00981058Phase 3Completed

First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin

Role: collaborator

NCT05743075Phase 3Completed

A Study to Evaluate the Efficacy and Safety of Ensifentrine for 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Role: collaborator

NCT05808699Active Not Recruiting

Camera Qualification Study

Role: collaborator

NCT04364503Recruiting

Compliant Analysis of Patient Samples and Data

Role: collaborator

NCT03740997Phase 4Completed

Study to Determine Safety and Dosage of OPTISON in Pediatric Participants

Role: collaborator

NCT06249997Phase 3Unknown

An Open-Label Study to Assess the Safety & Efficacy of Leniolisib in Japanese Patients With APDS

Role: collaborator

NCT05591079Phase 2Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASH

Role: collaborator